Remiszewski P, Kalinowski P, Dudek K, Grodzicki M, Paluszkiewicz R, Zieniewicz K, Krawczyk M
Department of General Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
Transplant Proc. 2011 Oct;43(8):3025-8. doi: 10.1016/j.transproceed.2011.08.026.
The aim of this study was to examine the survival of adult liver retransplant recipients depending on selected factors: time from the primary transplantation, cold ischemia time, indications for retransplantation, patient age and United Network for Organ Sharing (UNOS) status.
Between December 1989 and March 2011, we performed 43 orthotopic liver retransplantations (re-OLTs) among patients aged 20-62 years including 24 women and 19 men. The cold ischemia time was 250-820 minutes. UNOS status before re-OLT: UNOS 1 (n=19; 44%) UNOS 2A (n=15; 35%), and UNOS 2B (n=4; 9%). The time from OLT to re-OLT was 1-2, 146 days. The indications for re-OLT were arterial thrombosis (n=14; 33%), anastomotic biliary complication (n=3; 7%), recurrence of the original disease (n=9; 21%), hepatic vein thrombosis (n=1; 2%), primary nonfunction (PNF) dysfunction (n=2; [5%] /6 [14%]), de novo hepatitis C cirrhosis (n=2; 5%) and other etiologies (n=6; 14%).
The 6-year survival among the primary OLT group was 80% compared with 58% among the re-OLT group (P=.0001). One-year survivals in the re-OLT group according to UNOS status 1, 2A, and 2B were 47%, 60%, and 75%, respectively (P=.475). There was a low negative correlation between survival time and time between OLT and re-OLT. There was a low positive correlation between survival time and cold ischemia time. There was a low negative correlation between survival time and patient age.
There was a significant difference in survival between OLT and re-OLT. There was a correlation between survival time and time to re-OLTx; a shorter time corresponded to longer survival. There was a poor correlation between survival time and patient age. UNOS status before re-OLT and indication for re-OLTx influenced survival.
本研究旨在根据以下选定因素,探讨成人肝再次移植受者的生存率:首次移植后的时间、冷缺血时间、再次移植的指征、患者年龄及器官共享联合网络(UNOS)状态。
1989年12月至2011年3月期间,我们对年龄在20 - 62岁的患者进行了43例原位肝再次移植(re-OLT),其中女性24例,男性19例。冷缺血时间为250 - 820分钟。再次移植前的UNOS状态:UNOS 1(n = 19;44%),UNOS 2A(n = 15;35%),以及UNOS 2B(n = 4;9%)。首次移植至再次移植的时间为1 - 2,146天。再次移植的指征包括动脉血栓形成(n = 14;33%)、吻合口胆道并发症(n = 3;7%)、原发病复发(n = 9;21%)、肝静脉血栓形成(n = 1;2%)、原发性无功能(PNF)功能障碍(n = 2;[5%] /6 [14%])、新发丙型肝炎肝硬化(n = 2;5%)以及其他病因(n = 6;14%)。
首次肝移植组的6年生存率为80%,而再次移植组为58%(P = 0.0001)。再次移植组中,根据UNOS状态1、2A和2B划分的1年生存率分别为47%、60%和75%(P = 0.475)。生存时间与首次移植至再次移植的时间之间存在低度负相关。生存时间与冷缺血时间之间存在低度正相关。生存时间与患者年龄之间存在低度负相关。
首次肝移植与再次肝移植的生存率存在显著差异。生存时间与再次肝移植的时间之间存在相关性;时间越短,生存时间越长。生存时间与患者年龄之间的相关性较差。再次移植前的UNOS状态和再次移植的指征影响生存率。